News

Organizational insights and updates

  • Providence reports Q3 2024 results

    Providence reports Q3 2024 results

    Providence announced results for the three months ended September 30, 2024. The not-for-profit health system continued to improve performance while serving more people in need.

    Read Article
  • Two clinical trials for solid tumor cancers take different approaches to stop growth

    Two clinical trials for solid tumor cancers take different approaches to stop growth

    Two global studies open at Providence Cancer Institute will evaluate combinations of medications to help stop or slow the growth of cancer in solid tumors.

    Read Article
  • Providence names Darryl A. Elmouchi, M.D., next chief operating officer

    Providence names Darryl A. Elmouchi, M.D., next chief operating officer

    Providence selects Darryl A. Elmouchi, M.D., MBA, as its new chief operating officer, effective Jan. 2.

    Read Article
  • Comprehensive Genomic Profiling leads to better patient outcomes, new joint study says  

    Comprehensive Genomic Profiling leads to better patient outcomes, new joint study says  

    Real-world data from Providence, Illumina and Microsoft Research finds cancer patients with early genomic testing received better precision treatment, underlines urgency to become standard practice

    Read Article
  • Providence's Health Connect Partners achieves historic milestones in value-based care delivery with $137 million in savings to Medicare

    Providence's Health Connect Partners achieves historic milestones in value-based care delivery with $137 million in savings to Medicare

    Health Connect Partners (HCP), Providence's Medicare Shared Savings Program (MSSP) Accountable Care Organization (ACO), generated more than $137 million in savings to CMS in 2023.

    Read Article
  • Harnessing CAR T-cell therapy: A new study for indolent B-cell non-Hodgkin lymphoma

    Harnessing CAR T-cell therapy: A new study for indolent B-cell non-Hodgkin lymphoma

    New study evaluates a type of CAR T-cell therapy called liso-cel. Researchers will collect data from multiple groups in a study that may give patients hope for long-term remission and quality of life.

    Read Article
  • New studies test immunotherapy to boost breast cancer treatment and prevent return

    New studies test immunotherapy to boost breast cancer treatment and prevent return

    Explore promising clinical trials at Providence Cancer Institute that are investigating immunotherapy for early-stage TNBC and high-risk, HR-positive breast cancer.

    Read Article
  • Providence and Compassus announce joint venture for home-based care services

    Providence and Compassus announce joint venture for home-based care services

    Providence and Compassus have announced an agreement to form a joint venture partnership for home health, hospice, community-based palliative care, and private duty caregiving services.

    Read Article
  • Leading Health Systems Form New Organization to Transform the Development and Delivery of Health Care Solutions

    Leading Health Systems Form New Organization to Transform the Development and Delivery of Health Care Solutions

    Baylor Scott & White Health, Memorial Hermann Health System, Novant Health and Providence have announced the formation of Longitude Health.

    Read Article
  • Providence researchers identify factors that may influence MCED test adoption for communities facing health care access barriers

    Providence researchers identify factors that may influence MCED test adoption for communities facing health care access barriers

    Year-long study, published in Health Affairs Scholar, prompts need for multi-level intervention to increase adoption rates, combat cancer inequities

    Read Article
  • New data: Average primary care physician faces meeting 57 different quality measures each year

    New data: Average primary care physician faces meeting 57 different quality measures each year

    A study released today indicates that burden of quality measures may be counterproductive in patient care, suggests possible need for intervention

    Read Article
  • New Data: MedPearl clinical decision platform improves specialty referrals, boosts productivity, and reduces clinician time spent in the EMR

    New Data: MedPearl clinical decision platform improves specialty referrals, boosts productivity, and reduces clinician time spent in the EMR

    Data published in the New England Journal of Medicine Catalyst reported that MedPearl, a Providence-developed platform, improves primary care clinician productivity, decreases time waste.

    Read Article
  • Providence reports Q2 2024 results

    Providence reports Q2 2024 results

    Providence announced results for the three months ended June 30, 2024, which showed continued improvement in operating performance.

    Read Article
  • Can these new studies offer hope for people with lung and head and neck cancers?

    Can these new studies offer hope for people with lung and head and neck cancers?

    A new medication may help people with KRAS G12C-mutant non-small cell lung cancer. Read about the study and a trial evaluating an immunotherapy for treating head and neck squamous cell carcinoma.

    Read Article
  • Erik Wexler to serve as the next president and CEO for Providence

    Erik Wexler to serve as the next president and CEO for Providence

    The Providence St. Joseph Health Board of Directors announced that Providence Chief Operating Officer Erik Wexler has been named the health system’s next president and chief executive officer.

    Read Article
  • Furthering the Mission: Providence extends spiritual health services to caregivers and families through virtual offerings

    Furthering the Mission: Providence extends spiritual health services to caregivers and families through virtual offerings

    Supporting people in times of need, remote capabilities have enabled Providence chaplains to care for over 1,000 people since 2022.

    Read Article
  • Providence launches groundbreaking study to elevate real-world use of multi-cancer early detection

    Providence launches groundbreaking study to elevate real-world use of multi-cancer early detection

    Over the next three years, this study seeks to identify the patterns of access and use of cancer services among high-risk patients to understand how to guide them toward quality care.

    Read Article
  • Providence provides $2.1B in community benefit, including high-impact investments, in 2023

    Providence provides $2.1B in community benefit, including high-impact investments, in 2023

    Investments focus on addressing social determinants of health and ensuring continued access to vital care for those in need

    Read Article
  • Providence caregivers can build connection and awareness of community health needs through service

    Providence caregivers can build connection and awareness of community health needs through service

    Network members focus on helping caregivers address community health needs through service, advocacy, and giving.

    Read Article
  • Catholic Health Association of the United States names Orest Holubec chair-elect; Anna Newsom also joining board

    Catholic Health Association of the United States names Orest Holubec chair-elect; Anna Newsom also joining board

    CHA has named Providence Chief Communication Officer Orest Holubec as vice chairperson/chairperson-elect of the CHA Board of Trustees, while Chief Legal Officer Anna Newsom was elected to the Board.

    Read Article
  • loading
    Loading More...